2512
Mean time between initiation of gemcitabine therapy and onset of HUS was 7.4 +/- 3.5 months, or 21.9 +/- 10.9 doses of gemcitabine.
 HUS: Effect; 7.4 +/- 3.5 months, or 21.9 +/- 10.9 doses of gemcitabine: Treatment; gemcitabine: Treatment.Drug; 7.4 +/- 3.5 months: Treatment.Time_elapsed; 21.9 +/- 10.9 doses: Treatment.Dosage
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 HUS: Effect; 7.4 +/- 3.5 months, or 21.9 +/- 10.9 doses of gemcitabine: Treatment; gemcitabine: Treatment.Drug; 7.4 +/- 3.5 months: Treatment.Time_elapsed; 21.9 +/- 10.9 doses: Treatment.Dosage